Drugs & TargetsFree FDA approves Endari for patients with sickle cell disease July 07, 2017Vol.43 No.27
Drugs & Targets FDA approves Vectibix for use in wild-type ras metastatic colorectal cancer July 06, 2017Vol.40 No.06
Drugs & Targets FDA approves Vectibix for use in wild-type ras metastatic colorectal cancer June 30, 2017Vol.43 No.26
Drugs & Targets FDA approves flow cytometry test for leukemias and lymphomas June 30, 2017Vol.43 No.26
Drugs & Targets Novartis Kisqali receives positive CHMP opinion for HR+/HER2- locally advanced or metastatic breast cancer June 30, 2017Vol.43 No.26
Drugs & Targets Novartis receives EU approval for Zykadia in ALK-positive advanced non-small cell lung cancer June 30, 2017Vol.43 No.26
Drugs & Targets FDA approves Tafinlar and Mekinist for NSCLC with BRAF V600E mutation June 23, 2017Vol.43 No.25
Drugs & Targets FDA approves first companion diagnostic test to screen for multiple NSCLC therapies June 23, 2017Vol.43 No.25
